Navigation Links
MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results
Date:5/12/2008

aine program. Actual results may differ materially from current expectations based on risks and uncertainties affecting MAP Pharmaceuticals' business, including, without limitation, risks and uncertainties relating to the manufacture and qualification of clinical supply materials, our reliance on third-party manufacturers and the commencement, enrollment and conduct of clinical trials. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Annual Report on Form 10-K, filed with the SEC on March 20, 2008, and available at http://edgar.sec.gov.

MAP PHARMACEUTICALS, INC.

(a development stage enterprise)

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

March 31, December 31,

2008 2007

Assets

Current assets:

Cash, cash equivalents and short-term

investments $81,071 $94,990

Other current assets 859 1,079

Total current assets 81,930 96,069

Property and equipment, net 4,543 4,183

Restricted cash 321 321

Other assets 98 122

Total assets $86,892 $
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting ... . , Purchasing an accidental death and dismemberment rider ... type of rider provides benefits if the insured dies in ... lesser form of life insurance. , AD&D is not ...
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... Four years since the release of their debut ... the marriage of Avasa & Matthew Love – the duo are ... for release through White Swan Records on February 24, 2015. , ... sacred path available to all of us to walk out of ...
(Date:1/22/2015)... As interest in the value of spiritual ... worldwide, Rev. Eric J. Hall , president and CEO ... will be the keynote speaker on January 27 at an ... system. , The conference, “Hope and Resilience: Innovative and Interdisciplinary ...
(Date:1/22/2015)... Lower-Auto-Insurance.com has released a new blog post explaining the importance of ... the costs of an auto insurance policy . , Clients ... prices for their vehicle insurance policies. The safety a vehicle offers ... Because of this, drivers should always carry a first aid ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... The body parts industry, which suffered two recent scams, is ... United States . According to official reports, the billion-dollar industry ... call for a doubling of FDA inspections. ,From ... of inspections, and accordingly, the 153 searches, have uncovered no ...
... even after they stop smoking, says a new study, ... smoking ceases . ,The new finding is the ... with bronchial inflammation, it will continue even after they ... team of researchers in respiratory medicine including New Zealand ...
... international team of researchers has found evidence that people ... sleep disorder called restless legs syndrome (RLS) are ... ,RLS is a common and debilitating sleep disorder that ... people worldwide. It produces an intense, often irresistible urge ...
... even at the cost of lives, are turning out to ... are far less likely than whites to get specialized ... leave them more vulnerable to future fatal attacks. ... American Medical Association, tracked 1.2 million Medicare patients at least ...
... A US court has authorised Israeli generic medicines group Teva ... patent lawsuit by Novartis, the Swiss pharmaceutical group said on ... rejected on Monday a request from Novartis to stop Teva ... pending a trial in the case, the Swiss group said ...
... down on Madhya Pradesh Tuesday, taking temperatures to more than 46 ... heat wave claimed six more lives taking the toll to ... saying the hot weather would persist for the next two days. ... Morena and Damoh. ,The mercury soared to more ...
Cached Medicine News:Health News:Body Parts Industry Of U.S Under Investigation 2Health News:Boffins Find Link Between Common Sleep Disorder and Hypertension 2Health News:Racial Discrimination Takes The Nobility Out Of Doctoring 2
(Date:1/23/2015)... Jan. 23, 2015  Pete Rose, baseball,s all-time hits leader, is ... pain reliever Myoflex, Ducere Pharma has announced. "Pete,s ... excited to have him on board with Myoflex," said Ducere ... a legendary player who is known across all generations. The ...
(Date:1/23/2015)... available for sale, The Armor1 Ankle Roll Guard is a ... by cushioning the ankle from an inversion or "roll." ... of any shoe type and allows the user to ... against sprains. With customers in physical therapy, podiatry, and ...
(Date:1/23/2015)... Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that the number of ... compound, LB‑100, is being conducted, has been expanded from 1 ... M.D., the founder and President of Lixte, said that, "the ... site. Accrual of patients, however, was slower than projected. The ...
Breaking Medicine Technology:Pete Rose bets on Myoflex to relieve aches and pains 2The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... Stent with Polyzene(R)-F Surface Treatment Maximizes,Endothelialization; ... Antiplatelet Therapy, WASHINGTON, Oct. 13 ... and Futuristic Therapies" session during the ... sponsored by the Cardiovascular Research Foundation, ...
... Facet Solutions, Inc. today,announced the completion of 6 month ... The results show a 78% reduction in Oswestry Disability,Index ... Scores (VAS) for,symptomatic leg pain. Geoff Pardo, President & ... these early results, which thus far not,only demonstrate significant ...
Cached Medicine Technology:12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 212-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 312-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 4
Inquire...
Inquire...
... HV high-voltage power supply, 100-120 ... increased output of 5,000 V, ... Built-in infrared capability allows for ... and instructions are provided. Dimensions ...
... Form: Granular, free-flowing powder EEO (-m r ): ... 1.5C Remelt Point (1.5%): 88.0 1.5C Gel ... gm/cm 2 Gel Strength (1.5%): greater than ... less than or equal to 7% Turbidity (1.5%): ...
Medicine Products: